Could MDMA help treat OCD? new study investigates
NCT ID NCT05783817
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether MDMA (the active ingredient in ecstasy) combined with talk therapy can safely reduce OCD symptoms. About 40 adults with OCD who have not improved with standard treatments will receive either MDMA or a comparison drug during therapy sessions. The goal is to see if this approach lowers symptom severity and is well tolerated.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBSESSIVE-COMPULSIVE DISORDER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
Stanford University Medical Center
RECRUITINGPalo Alto, California, 94305, United States
Contact Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a single ketamine infusion quiet the obsessive mind?
- Can improv comedy help tame OCD?
- A Two-Year watch: can brain scans and surveys predict depression and anxiety in teens?
- Therapy may let kids with OCD ditch meds for good
- Could gut bacteria hold the key to childhood OCD?
- Can brain recordings unlock better OCD treatment?